Financial Performance - Record revenue of 1.6billionforQ32024,markingthebestquarterinCMEGrouphistory[2]−AdjustednetincomeforQ32024was977 million, with diluted earnings per share of 2.68[2]−TotalrevenuesforthequarterendedSeptember30,2024,were1,584.4 million, a 18.4% increase from 1,337.8millioninthesamequarterof2023[10]−Operatingincomeforthequarterwas1,024.2 million, up 24.8% from 820.2millionyear−over−year[10]−Netincomeattributabletocommonshareholderswas901.3 million, compared to 740.8millionintheprioryear,representinga21.7977.0 million, compared to 818.0millioninthesamequarterlastyear,reflectinga19.52.51 for Q3 2024, up from 2.06inQ32023[15]TradingVolume−Averagedailyvolume(ADV)reachedarecord28.3millioncontracts,witha281.3 billion, with an average rate per contract of 0.666[3]−Theaverageratepercontract(RPC)fortotaltradingwas0.666 in Q3 2024, down from 0.707inQ32023[13]−Investmentincomeforthequarterwas1,026.8 million, down from 1,272.5millioninthesamequarterofthepreviousyear[10]FinancialPosition−CashandcashequivalentsasofSeptember30,2024,totaledapproximately2.6 billion[3] - Total assets increased to 137.8billionasofSeptember30,2024,comparedto129.7 billion at the end of 2023[9] - Total liabilities rose to 109.6billion,withlong−termdebtat2.7 billion[9] Expenses - Total expenses for the quarter were 560.2million,anincreasefrom517.6 million in Q3 2023, reflecting a 8.2% rise[10] Shareholder Returns - The company returned approximately $25.6 billion to shareholders in dividends since 2012[3] Trading Days - The company reported a total of 636 trading days in Q3 2024, consistent with the previous quarter[11]